Dynaglipt-M Tablets SR is a combination of Metformin (a biguanide) and Teneligliptin (a DPP-4 inhibitor), designed for the effective management of type 2 diabetes mellitus. This extended-release formulation helps control blood sugar levels throughout the day by improving insulin sensitivity and enhancing incretin activity. It is typically prescribed when diet, exercise, and monotherapy are insufficient to achieve adequate glycemic control.

• Dual-action formula provides improved blood glucose regulation

• Metformin decreases hepatic glucose production and improves insulin sensitivity

• Teneligliptin enhances insulin secretion and suppresses glucagon levels

• Helps manage both fasting and postprandial blood sugar

• Supports long-term blood sugar control and reduces risk of complications

• Take once daily, preferably with the evening meal to reduce gastrointestinal side effects

• Swallow the tablet whole with water—do not crush or chew

• Maintain regular diet and exercise regimen for optimal results

• Follow your doctor’s instructions regarding dosage and timing

• Typical dose: One SR (sustained-release) tablet daily or as prescribed by the physician

• Do not exceed the recommended dose

• If you miss a dose, take it as soon as possible unless it's close to the next dose

• Do not double the dose to make up for a missed one

• Not recommended for patients with type 1 diabetes or diabetic ketoacidosis

• Use cautiously in those with kidney, liver, or heart conditions

• Regular blood glucose and renal function monitoring is advised

• Avoid alcohol to reduce the risk of lactic acidosis

• Inform your healthcare provider of all current medications

• Common:

• Nausea, vomiting, or stomach upset

• Headache or fatigue

• Rare but serious:

• Lactic acidosis (with Metformin)

• Hypoglycemia (especially when used with other antidiabetics)

• Allergic skin reactions

•  

• Diarrhea

• Store at room temperature below 30°C

• Keep in a dry place, away from moisture and direct sunlight

• Store in original packaging

• Keep out of reach of children

Q1. Can Dynaglipt-M be taken on an empty stomach?
It is best taken with meals, especially to reduce gastrointestinal discomfort caused by Metformin.

Q2. Is this combination safe for long-term use?
Yes, if used under medical supervision with regular monitoring, it is considered safe for long-term diabetes management.

Q3. Can it cause hypoglycemia?
It has a low risk of hypoglycemia unless combined with insulin or other antidiabetic medications.

Q4. Who should not use Dynaglipt-M?
Patients with severe kidney or liver dysfunction, or those at risk of lactic acidosis, should avoid using this medication.